vs
NEOGENOMICS INC（NEO）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是NEOGENOMICS INC的1.2倍（$217.4M vs $186.7M），Rapid7, Inc.净利率更高（1.4% vs -57.9%，领先59.3%），NEOGENOMICS INC同比增速更快（11.1% vs 0.5%），过去两年NEOGENOMICS INC的营收复合增速更高（6.5% vs 3.0%）
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
NEO vs RPD — 直观对比
营收规模更大
RPD
是对方的1.2倍
$186.7M
营收增速更快
NEO
高出10.6%
0.5%
净利率更高
RPD
高出59.3%
-57.9%
两年增速更快
NEO
近两年复合增速
3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $186.7M | $217.4M |
| 净利润 | $-108.0M | $3.1M |
| 毛利率 | 43.3% | 68.9% |
| 营业利润率 | 46.9% | 1.0% |
| 净利率 | -57.9% | 1.4% |
| 营收同比 | 11.1% | 0.5% |
| 净利润同比 | 42.0% | 44.1% |
| 每股收益（稀释后） | $-0.13 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEORPD
| Q1 26 | $186.7M | — | ||
| Q4 25 | $190.2M | $217.4M | ||
| Q3 25 | $187.8M | $218.0M | ||
| Q2 25 | $181.3M | $214.2M | ||
| Q1 25 | $168.0M | $210.3M | ||
| Q4 24 | $172.0M | $216.3M | ||
| Q3 24 | $167.8M | $214.7M | ||
| Q2 24 | $164.5M | $208.0M |
净利润NEORPD
| Q1 26 | $-108.0M | — | ||
| Q4 25 | — | $3.1M | ||
| Q3 25 | $-27.1M | $9.8M | ||
| Q2 25 | $-45.1M | $8.3M | ||
| Q1 25 | $-25.9M | $2.1M | ||
| Q4 24 | — | $2.2M | ||
| Q3 24 | $-17.7M | $15.4M | ||
| Q2 24 | $-18.6M | $6.5M |
毛利率NEORPD
| Q1 26 | 43.3% | — | ||
| Q4 25 | 43.8% | 68.9% | ||
| Q3 25 | 42.8% | 70.2% | ||
| Q2 25 | 42.6% | 70.6% | ||
| Q1 25 | 43.6% | 71.7% | ||
| Q4 24 | 44.9% | 69.5% | ||
| Q3 24 | 44.6% | 70.6% | ||
| Q2 24 | 44.1% | 70.7% |
营业利润率NEORPD
| Q1 26 | 46.9% | — | ||
| Q4 25 | -7.1% | 1.0% | ||
| Q3 25 | -14.4% | 2.7% | ||
| Q2 25 | -26.3% | 1.6% | ||
| Q1 25 | -16.6% | -0.0% | ||
| Q4 24 | -10.7% | 3.4% | ||
| Q3 24 | -12.6% | 6.0% | ||
| Q2 24 | -13.3% | 2.5% |
净利率NEORPD
| Q1 26 | -57.9% | — | ||
| Q4 25 | — | 1.4% | ||
| Q3 25 | -14.4% | 4.5% | ||
| Q2 25 | -24.9% | 3.9% | ||
| Q1 25 | -15.4% | 1.0% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | -10.5% | 7.2% | ||
| Q2 24 | -11.3% | 3.1% |
每股收益（稀释后）NEORPD
| Q1 26 | $-0.13 | — | ||
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.15 | ||
| Q2 25 | — | $0.13 | ||
| Q1 25 | — | $0.03 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | — | $0.21 | ||
| Q2 24 | — | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.1M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $828.8M | $154.7M |
| 总资产 | $1.3B | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEORPD
| Q1 26 | $146.1M | — | ||
| Q4 25 | $159.6M | $474.7M | ||
| Q3 25 | $164.1M | $407.1M | ||
| Q2 25 | $154.7M | $511.7M | ||
| Q1 25 | $346.2M | $493.5M | ||
| Q4 24 | $367.0M | $521.7M | ||
| Q3 24 | $362.0M | $443.7M | ||
| Q2 24 | $355.1M | $442.6M |
总债务NEORPD
| Q1 26 | — | — | ||
| Q4 25 | $341.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $541.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NEORPD
| Q1 26 | $828.8M | — | ||
| Q4 25 | $836.6M | $154.7M | ||
| Q3 25 | $838.3M | $127.2M | ||
| Q2 25 | $854.0M | $90.4M | ||
| Q1 25 | $888.3M | $52.7M | ||
| Q4 24 | $902.3M | $17.7M | ||
| Q3 24 | $908.2M | $-5.1M | ||
| Q2 24 | $915.9M | $-52.6M |
总资产NEORPD
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.4B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.4B | $1.6B | ||
| Q1 25 | $1.6B | $1.6B | ||
| Q4 24 | $1.6B | $1.7B | ||
| Q3 24 | $1.6B | $1.6B | ||
| Q2 24 | $1.6B | $1.5B |
负债/权益比NEORPD
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | — | $36.4M |
| 自由现金流率自由现金流/营收 | — | 16.8% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流NEORPD
| Q1 26 | $-8.1M | — | ||
| Q4 25 | $1.3M | $37.6M | ||
| Q3 25 | $8.9M | $39.0M | ||
| Q2 25 | $20.3M | $47.5M | ||
| Q1 25 | $-25.3M | $29.8M | ||
| Q4 24 | $9.8M | $63.8M | ||
| Q3 24 | $9.2M | $44.0M | ||
| Q2 24 | $13.9M | $32.9M |
自由现金流NEORPD
| Q1 26 | — | — | ||
| Q4 25 | $-6.5M | $36.4M | ||
| Q3 25 | $570.0K | $34.8M | ||
| Q2 25 | $14.0M | $46.6M | ||
| Q1 25 | $-29.8M | $28.4M | ||
| Q4 24 | $-1.8M | $62.6M | ||
| Q3 24 | $-1.6M | $42.6M | ||
| Q2 24 | $814.0K | $32.6M |
自由现金流率NEORPD
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | 16.8% | ||
| Q3 25 | 0.3% | 16.0% | ||
| Q2 25 | 7.7% | 21.8% | ||
| Q1 25 | -17.8% | 13.5% | ||
| Q4 24 | -1.0% | 28.9% | ||
| Q3 24 | -0.9% | 19.9% | ||
| Q2 24 | 0.5% | 15.7% |
资本支出强度NEORPD
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 0.5% | ||
| Q3 25 | 4.4% | 1.9% | ||
| Q2 25 | 3.5% | 0.4% | ||
| Q1 25 | 2.7% | 0.6% | ||
| Q4 24 | 6.7% | 0.5% | ||
| Q3 24 | 6.4% | 0.6% | ||
| Q2 24 | 8.0% | 0.1% |
现金转化率NEORPD
| Q1 26 | — | — | ||
| Q4 25 | — | 12.01× | ||
| Q3 25 | — | 3.97× | ||
| Q2 25 | — | 5.70× | ||
| Q1 25 | — | 14.14× | ||
| Q4 24 | — | 29.36× | ||
| Q3 24 | — | 2.85× | ||
| Q2 24 | — | 5.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEO
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
